David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Emerson Electric
EMR
|
+$546M |
| 2 |
Amazon
AMZN
|
+$515M |
| 3 |
Tesla
TSLA
|
+$389M |
| 4 |
Netflix
NFLX
|
+$322M |
| 5 |
Adobe
ADBE
|
+$305M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$836M |
| 2 |
CELG
Celgene Corp
CELG
|
+$460M |
| 3 |
NVIDIA
NVDA
|
+$429M |
| 4 |
ConocoPhillips
COP
|
+$311M |
| 5 |
Biogen
BIIB
|
+$301M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.8% |
| 2 | Consumer Discretionary | 11.76% |
| 3 | Healthcare | 10.16% |
| 4 | Financials | 7.89% |
| 5 | Industrials | 6.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
876
PUT
Lear
LEA
$8.24B
| $16.9M | 0.02% |
122,900
+100
| +0.1% | +$12.4K |
|
877
CALL
Accenture
ACN
$114B
| $16.8M | 0.02% |
80,000
+28,000
| +54% | +$5.46M |
|
878
PUT
PepsiCo
PEP
$195B
| $16.8M | 0.02% |
122,900
-60,100
| -33% | -$8.18M |
|
879
Teck Resources
TECK
$34.8B
| $16.8M | 0.02% |
968,534
+307,545
| +47% | +$5.02M |
|
880
Bio-Techne
TECH
$11.3B
| $16.8M | 0.02% |
305,776
+6,460
| +2% | +$339K |
|
881
Upbound Group
UPBD
$1.12B
| $16.8M | 0.02% |
581,604
-129,967
| -18% | -$3.4M |
|
882
PUT
Transocean
RIG
$6.43B
| $16.8M | 0.02% |
2,435,600
-1,484,700
| -38% | -$7.65M |
|
883
CALL
Elevance Health
ELV
$86.6B
| $16.7M | 0.02% |
55,300
+12,900
| +30% | +$3.55M |
|
884
Thomson Reuters
TRI
$45.8B
| $16.7M | 0.02% |
221,463
-150,638
| -40% | -$11M |
|
|
EVBG
885
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $16.7M | 0.02% |
213,614
-50,115
| -19% | -$3.87M |
|
886
MetLife
MET
$60.4B
| $16.7M | 0.02% |
326,852
-759,735
| -70% | -$36.7M |
|
887
Anika Therapeutics
ANIK
$288M
| $16.6M | 0.02% |
320,382
-87,912
| -22% | -$5.11M |
|
888
Gibraltar Industries
ROCK
$1.38B
| $16.6M | 0.02% |
329,345
+146,636
| +80% | +$7.36M |
|
|
BLUE
889
CALL
DELISTED
bluebird bio
BLUE
| $16.6M | 0.02% |
14,599
+1,884
| +15% | +$2.05M |
|
890
AdvanSix
ASIX
$443M
| $16.6M | 0.02% |
830,963
+15,815
| +2% | +$346K |
|
891
CALL
KLA
KLAC
$239B
| $16.6M | 0.02% |
930,000
+372,000
| +67% | +$6.24M |
|
892
Viavi Solutions
VIAV
$9.26B
| $16.5M | 0.02% |
1,101,260
+185,380
| +20% | +$2.77M |
|
|
VRTSP
893
DELISTED
Virtus Investment Partners, Inc. 7.25% Series D Mandatory Convertible Preferred Stock
VRTSP
| $16.5M | 0.02% |
162,645
| – | – |
|
|
AGN
894
CALL
DELISTED
Allergan plc
AGN
| $16.5M | 0.02% |
86,100
| – | – |
|
895
Fox Class A
FOXA
$29.1B
| $16.5M | 0.02% |
443,906
+44,697
| +11% | +$1.53M |
|
|
TWTR
896
CALL
DELISTED
Twitter, Inc.
TWTR
| $16.5M | 0.02% |
513,300
-434,400
| -46% | -$14.3M |
|
897
ServiceNow
NOW
$132B
| $16.4M | 0.02% |
290,425
-471,030
| -62% | -$24.8M |
|
|
BDXA
898
DELISTED
Becton, Dickinson and Company Depositary Shares, each Representing a 1/20th Interest in a Share of 6
BDXA
| $16.4M | 0.02% |
250,000
| – | – |
|
899
PUT
Philip Morris
PM
$297B
| $16.4M | 0.02% |
192,300
-46,000
| -19% | -$3.79M |
|
900
Applied Materials
AMAT
$385B
| $16.3M | 0.02% |
267,689
-1,668,665
| -86% | -$93.8M |
|
Similar funds
David Shaw's Q4 2019 Portfolio in Review
As of Q4 2019, David Shaw held 4,337 positions worth $87.5B, up 7.7% from $81.2B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
David Shaw's Q4 2019 filing shows 572 new, 1,477 increased, 1,498 reduced and 412 closed positions. Its largest new stake was Tesla: 17,953,230 shares worth $501M. The largest sale was Alibaba, an estimated $836M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- David Shaw's largest Q4 2019 buy was Tesla: 17,953,230 shares worth $501M.
- David Shaw added most to Emerson Electric in Q4 2019, an estimated $546M increase.
- David Shaw's biggest Q4 2019 reduction was Alibaba, cutting an estimated $836M.
- David Shaw fully exited Celgene Corp in Q4 2019, selling an estimated $460M.
- David Shaw's ten largest holdings make up 10% of its $87.5B portfolio in Q4 2019.
- David Shaw opened 572 new positions and closed 412 in Q4 2019.
- David Shaw's portfolio value rose 7.7% quarter-over-quarter to $87.5B.
Based on D.E. Shaw & Co's 13F filing for Q4 2019, filed 14 Feb 2020.